Precision Antimicrobial Therapy: Beyond Technology, Towards a New Stewardship Paradigm
Health Innovation Reports · 2026
DOI: 10.64048/hir.v2n2.007 ↗Abstract
Antimicrobial resistance (AMR) represents a critical global challenge, demanding a shift from empirical to personalized treatment approaches. Precision antimicrobial therapy, incorporating artificial intelligence (AI), rapid diagnostics, and genomics, offers a revolutionary opportunity for advancement. However, it is argued that the effectiveness of this strategy will rely less on isolated technological breakthroughs and more on the fundamental reconfiguration of clinical workflows and Antimicrobial Stewardship (AMS) programs. This perspective suggests that the true value of these technologies is not found in automation, but in their capacity to enable a new generation of “data-driven” clinicians who can synthesize complex, real-time information about pathogen and host. While there are considerable obstacles related to cost, infrastructure, and data governance, a tiered implementation model is proposed to prioritize actionable interventions. Ultimately, precision antimicrobial therapy can redefine infectious disease management, but only if it emphasizes implementation science, interdisciplinary collaboration, and global equity alongside technological progress.
EUVIMED